From: Superior mesenteric vein thrombosis due to COVID-19 vaccination: a case report
No | Year/Author | Age | Gender | Pre-existing disease | Type of vaccination | Time from vaccination to onset | Anti-PF4 antibody | Treatment | Outcome |
---|---|---|---|---|---|---|---|---|---|
1 | 2022/Bogovic et al. [8] | 40 | Male | – | ChAdOx1 nCoV-19 | 10 days | Negative | IVIG, IVR, Operation | Alive |
2 | 2021/Schultz et al. [12] | 32 | Male | Asthma | ChAdOx1 nCoV-19 | 7Â days | Positive | LMWH, IVIG | Alive |
3 | 2021/Scully et al. [12] | 55 | Female | – | ChAdOx1 nCoV-19 | 6 days | Unknown | – | Dead |
4 | 2021/Scully et al. [13] | 54 | Male | – | ChAdOx1 nCoV-19 | 10 days | Negative | – | Dead |
5 | 2021/Umbrello et al. [14] | 36 | Female | Asthma | ChAdOx1 nCoV-19 | unknown | Positive | Unfractioned heparin | Alive |
6 | 2021/Fanni et al. [15] | 58 | Male | – | ChAdOx1 nCoV-19 | 13 days | Unknown | – | Dead |
7 | Our case | 80 | Male | Hypertension, Hyperuricemia, Prostate cancer | mRNA-1273 | 6Â days | Negative | Unfractioned heparin | Alive |